Study of the diagnostic value of the dexamethasone suppression test in endogenous depression

Abstract The diagnostic value of the dexamethasone suppression test (DST) in “endogenous” depression was evaluated in 209 psychiatric inpatients. A high incidence of abnormal DST results was observed in “endogenous” depressives (52%), schizo-affective (69%) and borderline patients (38%). However, 25% of the patients with other psychiatric disease also failed to suppress on the DST. Diagnostic criteria, previous history of alcoholism, psychiatric drug treatment, age and sex did not significantly affect DST performance. The present data do not indicate that the DST represents a highly specific marker of “endogenous” depression.